Should patents on life-saving medicines and vaccines be suspended so that developing countries can produce them affordably?
Founding phase
0persons
You can be one of the first: train your twin and share it to the network.
The simulation shows what this page will look like with thousands of twins. None of it feeds into real results.
Context
During COVID-19, millions died in countries that could not afford vaccines — while pharmaceutical companies made record profits. The WTO allows temporary patent suspensions, but pharmaceutical corporations lobby against them. The debate between innovation incentives and global health access remains unresolved.
Real-world source
WTO Ministerial Conference (MC12) · 6/17/2022
Ministerial Decision on the TRIPS Agreement, WT/MIN(22)/30 — COVID-19 vaccine patent flexibilities
Related questions
Should a universal citizens' health insurance be introduced, into which everyone — including the self-employed and civil servants — contributes?→Should parents be allowed to edit their children’s genes to rule out severe hereditary diseases?→Should research into radical life extension — well beyond 100 years — be advanced with public funding?→